Aeroflex Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 8, 2025, 4:37 am

Competitors of Aeroflex Industries Ltd

All Competitor Stocks of Aeroflex Industries Ltd

Quarterly Result

Last Updated: August 1, 2025, 8:20 am

Below is a detailed analysis of the quarterly data for Aeroflex Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 79.19 Cr.. The value appears to be declining and may need further review. It has decreased from 94.23 Cr. (Mar 2025) to 79.19 Cr., marking a decrease of 15.04 Cr..
• For Expenses, as of Jun 2025, the value is 63.65 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 75.84 Cr. (Mar 2025) to 63.65 Cr., marking a decrease of 12.19 Cr..
• For Operating Profit, as of Jun 2025, the value is 15.54 Cr.. The value appears to be declining and may need further review. It has decreased from 18.39 Cr. (Mar 2025) to 15.54 Cr., marking a decrease of 2.85 Cr..
• For OPM %, as of Jun 2025, the value is 19.62%. The value appears strong and on an upward trend. It has increased from 19.52% (Mar 2025) to 19.62%, marking an increase of 0.10%.
• For Other Income, as of Jun 2025, the value is 0.33 Cr.. The value appears strong and on an upward trend. It has increased from 0.27 Cr. (Mar 2025) to 0.33 Cr., marking an increase of 0.06 Cr..
• For Interest, as of Jun 2025, the value is 0.18 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.13 Cr. (Mar 2025) to 0.18 Cr., marking an increase of 0.05 Cr..
• For Depreciation, as of Jun 2025, the value is 5.48 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.88 Cr. (Mar 2025) to 5.48 Cr., marking an increase of 1.60 Cr..
• For Profit before tax, as of Jun 2025, the value is 10.21 Cr.. The value appears to be declining and may need further review. It has decreased from 14.65 Cr. (Mar 2025) to 10.21 Cr., marking a decrease of 4.44 Cr..
• For Tax %, as of Jun 2025, the value is 25.27%. The value appears to be increasing, which may not be favorable. It has increased from 24.16% (Mar 2025) to 25.27%, marking an increase of 1.11%.
• For Net Profit, as of Jun 2025, the value is 7.62 Cr.. The value appears to be declining and may need further review. It has decreased from 11.11 Cr. (Mar 2025) to 7.62 Cr., marking a decrease of 3.49 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.59. The value appears to be declining and may need further review. It has decreased from 0.86 (Mar 2025) to 0.59, marking a decrease of 0.27.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 4:02 am

Growth

Last Updated: September 5, 2025, 2:06 pm

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Aeroflex Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 4.06. This value is below the healthy minimum of 5. It has increased from 3.39 (Mar 24) to 4.06, marking an increase of 0.67.
• For Diluted EPS (Rs.), as of Mar 25, the value is 4.06. This value is below the healthy minimum of 5. It has increased from 3.39 (Mar 24) to 4.06, marking an increase of 0.67.
• For Cash EPS (Rs.), as of Mar 25, the value is 4.93. This value is within the healthy range. It has increased from 3.71 (Mar 24) to 4.93, marking an increase of 1.22.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 26.48. It has increased from 22.67 (Mar 24) to 26.48, marking an increase of 3.81.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 26.48. It has increased from 22.67 (Mar 24) to 26.48, marking an increase of 3.81.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 29.09. It has increased from 24.58 (Mar 24) to 29.09, marking an increase of 4.51.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 6.31. This value is within the healthy range. It has increased from 5.08 (Mar 24) to 6.31, marking an increase of 1.23.
• For PBIT / Share (Rs.), as of Mar 25, the value is 5.44. This value is within the healthy range. It has increased from 4.59 (Mar 24) to 5.44, marking an increase of 0.85.
• For PBT / Share (Rs.), as of Mar 25, the value is 5.41. This value is within the healthy range. It has increased from 4.43 (Mar 24) to 5.41, marking an increase of 0.98.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 4.06. This value is within the healthy range. It has increased from 3.23 (Mar 24) to 4.06, marking an increase of 0.83.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 4.06. This value is within the healthy range. It has increased from 3.23 (Mar 24) to 4.06, marking an increase of 0.83.
• For PBDIT Margin (%), as of Mar 25, the value is 21.68. This value is within the healthy range. It has increased from 20.65 (Mar 24) to 21.68, marking an increase of 1.03.
• For PBIT Margin (%), as of Mar 25, the value is 18.68. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 18.68.
• For PBT Margin (%), as of Mar 25, the value is 18.59. This value is within the healthy range. It has increased from 18.00 (Mar 24) to 18.59, marking an increase of 0.59.
• For Net Profit Margin (%), as of Mar 25, the value is 13.95. This value exceeds the healthy maximum of 10. It has increased from 13.12 (Mar 24) to 13.95, marking an increase of 0.83.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 13.95. This value is within the healthy range. It has increased from 13.12 (Mar 24) to 13.95, marking an increase of 0.83.
• For Return on Networth / Equity (%), as of Mar 25, the value is 15.33. This value is within the healthy range. It has increased from 14.23 (Mar 24) to 15.33, marking an increase of 1.10.
• For Return on Capital Employeed (%), as of Mar 25, the value is 20.41. This value is within the healthy range. It has increased from 20.20 (Mar 24) to 20.41, marking an increase of 0.21.
• For Return On Assets (%), as of Mar 25, the value is 12.30. This value is within the healthy range. It has increased from 11.12 (Mar 24) to 12.30, marking an increase of 1.18.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.93. It has decreased from 1.08 (Mar 24) to 0.93, marking a decrease of 0.15.
• For Current Ratio (X), as of Mar 25, the value is 2.91. This value is within the healthy range. It has decreased from 3.46 (Mar 24) to 2.91, marking a decrease of 0.55.
• For Quick Ratio (X), as of Mar 25, the value is 2.10. This value exceeds the healthy maximum of 2. It has decreased from 2.73 (Mar 24) to 2.10, marking a decrease of 0.63.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.99. This value is within the healthy range. It has increased from 3.61 (Mar 24) to 5.99, marking an increase of 2.38.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 6.15. This value is below the healthy minimum of 20. It has increased from 5.47 (Mar 24) to 6.15, marking an increase of 0.68.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 5.06. This value is below the healthy minimum of 20. It has increased from 4.76 (Mar 24) to 5.06, marking an increase of 0.30.
• For Earning Retention Ratio (%), as of Mar 25, the value is 93.85. This value exceeds the healthy maximum of 70. It has decreased from 94.53 (Mar 24) to 93.85, marking a decrease of 0.68.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 94.94. This value exceeds the healthy maximum of 70. It has decreased from 95.24 (Mar 24) to 94.94, marking a decrease of 0.30.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 227.11. This value is within the healthy range. It has increased from 30.70 (Mar 24) to 227.11, marking an increase of 196.41.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 147.18. This value is within the healthy range. It has increased from 20.51 (Mar 24) to 147.18, marking an increase of 126.67.
• For Enterprise Value (Cr.), as of Mar 25, the value is 2,174.22. It has increased from 1,465.00 (Mar 24) to 2,174.22, marking an increase of 709.22.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 5.78. This value exceeds the healthy maximum of 3. It has increased from 4.61 (Mar 24) to 5.78, marking an increase of 1.17.
• For EV / EBITDA (X), as of Mar 25, the value is 26.65. This value exceeds the healthy maximum of 15. It has increased from 22.31 (Mar 24) to 26.65, marking an increase of 4.34.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 5.85. This value exceeds the healthy maximum of 3. It has increased from 4.94 (Mar 24) to 5.85, marking an increase of 0.91.
• For Retention Ratios (%), as of Mar 25, the value is 93.84. This value exceeds the healthy maximum of 70. It has decreased from 94.52 (Mar 24) to 93.84, marking a decrease of 0.68.
• For Price / BV (X), as of Mar 25, the value is 6.43. This value exceeds the healthy maximum of 3. It has increased from 5.36 (Mar 24) to 6.43, marking an increase of 1.07.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 5.85. This value exceeds the healthy maximum of 3. It has increased from 4.94 (Mar 24) to 5.85, marking an increase of 0.91.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness